Literature DB >> 3879218

Hydrolysis of third-generation cephalosporins by Enterobacter cloacae beta-lactamase.

W Cullmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3879218     DOI: 10.1007/bf02013414

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

2.  Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12.

Authors:  F Yoshimura; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

3.  Investigations on beta-lactamase stability of recently developed beta-lactam compounds: study of enzyme kinetics.

Authors:  W Cullmann; W Dick
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-05

4.  Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.

Authors:  H Vu; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

5.  Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.

Authors:  A H Seeberg; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

6.  Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

  6 in total
  1 in total

1.  Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics.

Authors:  W Cullman; K H Büscher; W Dick
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.